Consumer health and safety is the fundamental responsibility of a pharmaceutical company. A major threat to the industry’s credibility is the rampant ...
A unicorn startup, a company with a valuation over $1 billion, is a rare beast. According to a September 2021 report by CB Insights, there are only ...
Contract manufacturers in the life sciences space face a host of challenges, including regulatory demands, thin margins, changing requirements based ...
